Introduction
Reversible protein phosphorylation plays an important role in the regulation of the cell cycle and apoptosis, which are the two major mechanisms to control the cell number. Pathways that control these two processes are often linked to each other. It is thus not surprising that protein phosphatase 1 (PP1), one of the major mammalian serine/threonine-speci®c phosphatases ubiquitously expressed, is involved in dierent aspects of cell growth control (Berndt, 1999) and may be a target for cancer therapy (Berndt, 2000) .
The assignment of speci®c roles in various cellular processes to PP1 is complicated by the fact that mammalian PP1 comprises four isozymes (1a, 1d, 1g1, 1g2) which can bind to many non-substrate cellular proteins functioning as regulatory subunits (Damer et al., 1998) . These subunits modify PP1's activity or target it to particular locales and substrates.
PP1 appears to play several roles in cell cycle regulation. In organisms from S. pombe to humans, PP1 activity is required for the exit from mitosis (Axton et al., 1990; Booher and Beach, 1989; Cheng et al., 2000; Fernandez et al., 1992; Ohkura et al., 1989) , although the essential mitotic substrate(s) for PP1 have not yet been identi®ed. Meanwhile we have found that phosphorylation of a C-terminal threonine (Thr320) in mammalian PP1a by Cdks inhibits its activity in vitro (Dohadwala et al., 1994) . This site is phosphorylated in vivo in S. pombe at the onset of mitosis (Yamano et al., 1994) and in human cells in mitosis (Kwon et al., 1997; Liu et al., 1999) and in late G1 until early S phase (Liu et al., 1999) . This indicates that control of PP1 function by regulatory subunits may not be sucient, but also requires post-translational modi®cation of the catalytic subunit itself, at least in the context of the cell cycle. Several laboratories including ours have identi®ed PP1 to be responsible for the dephosphorylation of pRB during the M/G1 transition (Alberts et al., 1993; Berndt, 1995; Durfee et al., 1993; Ludlow et al., 1993) and G0/G1 phase (Berndt, 1995) . In fact, the inactivation of PP1a by Cdks during the G1/S transition appears to be linked to the concomitant inhibition of pRB: Thus, in human cells expressing intact pRB, constitutively active PP1a (PP1aT320A) prevents pRB phosphorylation and progression into S phase (Berndt et al., 1997) . Consistent with this result, G1/S phosphorylation aects only pRB-associated PP1a (Liu et al., 1999) . Furthermore, in cells that cannot phosphorylate pRB or do not express pRB, PP1a causes increased cell death, giving rise to the speculation that it is the phosphorylated form of pRB, rather than RB per se, that protects cells from apoptosis (Berndt et al., 1997) .
These ®ndings appear to be in con¯ict with reports that suggested an inhibitory role for pRB in apoptosis, a notion that is dicult to reconcile with its established role as a tumor suppressor. Thus, massive cell death occurs in mice lacking pRB expression (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . Consistent with these data, overexpression of wild-type pRB in pRB-lacking tumor cells inhibits apoptosis (Berry et al., 1996; Fan et al., 1996; Haas-Kogan et al., 1995) . More recently, pRB was found to be cleaved by ICElike proteases during apoptosis generating a 42-aminoacid or 5-kDa peptide from its C terminus (Chen et al., 1997; JaÈ nicke et al., 1996) . These data suggest that pRB belongs to the so-called death substrates which need to be destroyed in order to launch or execute apoptosis. However, since none of the above studies addressed the role that the pRB phosphorylation status may play in apoptosis, we concluded that the exact function of pRB in apoptosis remains ill-de®ned.
Similarly, the function of protein phosphatases in apoptosis is controversial. Thus, prolonged exposure of cells to phosphatase inhibitors such as okadaic acid has been shown to cause cell cycle arrest (SchoÈ nthal and Feramisco, 1993; Taylor et al., 2000; Zheng et al., 1991) or apoptosis (Bùe et al., 1991; Inomata et al., 1995; Morimoto et al., 1997) . In contrast, apart from our own observations described above, a positive role for protein phosphatases in cell death was suggested by earlier ®ndings that apoptosis in human tumor cells is associated with the dephosphorylation of several proteins (Baxter and Lavin, 1992) and that protein phosphatase activity is necessary during early apoptosis in plants (Dunigan and Madlener, 1995) . Moreover, induction of apoptosis by cytosine arabinoside (araC) in HL-60 cells leads to dephosphorylation of pRB by an unidenti®ed phosphatase (Dou et al., 1995) . In the present study, we sought to characterize the role of PP1 in apoptosis, with an emphasis on the mechanism of interaction between PP1, pRB and caspases. Using HL-60 leukemia cells treated with araC, we found that PP1 activity rapidly and transiently increased approximately 30%, which was accompanied by a twofold increase in the amount of PP1a protein. This was followed by pRB dephosphorylation and then the proteolytic release of a short peptide from pRB's C terminus. We also demonstrate that phospho-pRB was a poor substrate for caspase-3 in vitro, while prior dephosphorylation by PP1a converts phospho-pRB into an ecient caspase-3 substrate. We further show that PP1a activity induced apoptosis in HL-60 cells as well as araC-resistant cells, and that inhibitor-2 prevented PP1a-dependent apoptosis.
Results

Induction of PP1a precedes araC-induced apoptosis
In order to investigate PP1's role in apoptosis, HL-60 cells were synchronized at the G1/S boundary by aphidicolin and exposed to 10 mM araC for 2 h. Then the cells were incubated for another 24 h in the absence of the drug. At several intervals, samples were collected and subjected to Western blot analysis, PP1 activity assay, DNA fragmentation assay, trypan blue staining and¯ow cytometry (Figure 1) . The Western blots, PP1 activity and DNA fragmentation assays are based on equal cell number or equal protein. The data show that following araC treatment, PP1a protein more than doubled its amount 3 h after release from araC, whereas of the other PP1 isozymes, PP1d increased approximately twofold at 24 h after release from araC, and PP1g1 remained unaected ( Figure  1a ). We also observed that PP1 activity increased by about 30% (Figure 1b) . Meanwhile, high molecular weight pRB gradually disappeared in favor of a fastermigrating species (Figure 1c) , which is indicative of either dephosphorylation or proteolytic cleavage or both (Tan and Wang, 1998) . The DNA fragmentation assay, trypan blue staining and¯ow cytometry analysis demonstrated that araC indeed induced apoptosis in G1/S synchronized HL-60 cells: they showed the typical features of apoptosis ± the appearance of DNA laddering (Figure 1d ), cells with 52n DNA content (Figure 1e) , and dying or dead cells (Figure 1e ). The degree of synchronization and the progression through the cell cycle of treated cells is summarized in Table 1 . Considering the succession of events, we notice that PP1 activity started to increase within 1 h of araC treatment and reached its peak at 1 h following the termination of exposure to araC. DNA laddering and apoptotic peaks in¯ow cytometric analyses appeared at about 2 h after release from araC, and ®nally, cells positive for trypan blue showed up at 6 h following araC treatment. The observed order of events suggests that during S phase, PP1a, but not other PP1 isozymes, may critically be involved in launching apoptosis.
It should be noted that etoposide-and actinomycin D-induced apoptosis was also associated with an The data shown correspond to the experiment shown in Figure 1 . Note that the cells in the G1, S, and G2/M phases were calculated to yield 100%, although as cells with 52n DNA content accumulate, the proportion of cells still proceeding through the cell cycle decrease accordingly induction of PP1a protein and increase of PP1 activity in HeLa cells (data not shown).
The mobility shift of pRB in response to araC is associated with dephosphorylation and cleavage
During the last decade, many laboratories have studied the phosphorylation state of pRB by simple Western blot without prior 32 P-labeling. This was justi®able by the early observation that phosphorylation of pRB is associated with an increase of the apparent M r by about 5 ± 10 kDa on SDS gels. Following the discovery of a caspase-liberated 5 kDa peptide from the C terminus of pRB (Chen et al., 1997) , this technique has to be approached with caution, since a Western blot with a generic pRB antibody would not be able to reveal whether the downward mobility shift in pRB is due to dephosphorylation or proteolysis. Therefore, we carried out another experiment in which the cells were labeled with 32 P-inorganic phosphate prior to Western blotting with sc-102 (a monoclonal antibody to the A/B pocket region of pRB) and Rb-C (a polyclonal antibody to the C-terminal 15 amino acids), the rationale being that sc-102 would detect both intact and C-terminally truncated RB, and Rb-C would only recognize intact pRB. Following the metabolic labeling and araC treatment (see Materials and methods), pRB was immunoprecipitated with sc-102 and then visualized by autoradiography and immunoblotting with sc-102 and Rb-C, respectively. Figure 2a shows that, in untreated cells, pRB was being phosphorylated, as was expected at the entry into S phase (upper panel). On the other hand, within 2 h after releasing the treated cells from araC, pRB had lost most of its phosphate. This corresponded to the appearance of fast-migrating pRB, also at 2 h after release from araC ( Figure 2b , upper panel). The signal produced by the antibody reacting with the C-terminus of pRB suggested that pRB was being cleaved shortly after its dephosphorylation ( Figure 2b , lower panel).
pRB dephosphorylation precedes pRB cleavage
To determine whether the cleavage of pRB associated with apoptosis occurs simultaneously with, or after dephosphorylation, we repeated the above experiment, using a shorter observation time (2 h after release from araC) and shorter intervals (15 min) between taking samples. This revealed that within 15 min of araC removal, pRB was being dephosphorylated, as evidenced by the loss of phosphate ( Figure 3a , lower panel) and the appearance of a low M r form of pRB at 30 min after release from araC ( Figure 3b , upper panel), whereas the loss of intact pRB occurred much Figure 1 AraC-induced apoptosis is associated with activation of PP1. Human HL-60 cells were synchronized at the G1/S boundary with aphidicolin and exposed to 10 mM araC for 2 h. Following removal of both drugs by several washes with culture medium, the cells were incubated for another 24 h and subjected to dierent analyses. (a) Western blots for the three ubiquitously expressed PP1 isozymes a, g1, and d show that PP1a amounts increased about twofold at 2 ± 3 h after release from araC. (b) PP1 activity, measured with 32 P-phosphorylase a as a substrate, transiently increased by approximately 30%. The graph shows the average of ®ve experiments+standard deviation. (c) Western blots for pRB with sc-102 show that, 1 ± 3 h after release from araC, the slow-migrating form pRB gradually disappeared in favor of fast-migrating pRB, suggesting that it got dephosphorylated, proteolytically cleaved, or both. (d) Cells degrade their DNA, beginning at about 2 h after release from araC. The ®rst lane shows DNA size markers. (e) FACS analysis reveals that cells with a DNA content 52n were beginning to appear at 5 h after release from araC (grey), whereas dying/dead (trypan-blue positive) cells appeared in two waves: a small increase of dying cells was seen immediately after removal of araC, and a more signi®cant increase to about 40% was seen between 6 and 20 h after release from araC (black) later, namely at 105 min after release from araC ( Figure 3b , lower panel). The increase in pRB phosphorylation observed at 105 and 120 min after release from araC was most likely due to imperfect synchronization of the cells in this particular experiment. It should be noted that we never saw such an increase in phosphate content in four independent experiments using the longer time intervals (cf. Figure  2 ).
Dephosphorylation is required to turn phospho-pRB into an efficient caspase-3 substrate in vitro
The above experiments suggest that, when cells committed to enter S phase are treated with apoptotic stimuli, pRB is dephosphorylated by increased PP1 activity and then cleaved by caspases. This could mean that pRB, but not phospho-pRB, is a suitable caspase substrate. In other words, does phosphorylation by Cdks protect pRB from proteolytic digestion, and does PP1 convert phosphorylated pRB into a substrate for proteolysis? In order to explore this further, we incubated in vitro phosphorylated pRB with caspase-3 with or without prior dephosphorylation by PP1a. In these experiments, we used recombinant pRB, Cdk2/ cyclin A, Cdk2/cyclin E, Cdk4/cyclin D1, and PP1a. Assuming that the ICE-like protease cleavage site in pRB corresponds to the C-terminal amino acids 883 ± 887 (DEADG) (JaÈ nicke et al., 1996) , we chose to employ caspase-3 whose preferred sequence is a very similar motif DEVDG (Lazebnik et al., 1994) . Equal amounts of pRB were incubated with Cdk/cyclin complexes, either individually or jointly, in the presence of [g-32 P]ATP. After phosphorylation, phos- Figure 2 , except that the observation period was shortened to 2 h and the intervals for taking samples were reduced to 15 min, in order to see whether dephosphorylation and cleavage of pRB are simultaneous or successive events. As in Figure 2 , all panels were prepared from one experiment. The vertical arrows indicate noticeable changes in the phosphate content or migration pattern of pRB. (a) Autoradiography of immunoprecipitated pRB electrotransferred to Immobilon-P membranes. Similar to Figure 2 , pRB had lost about 80% of its phosphate at 75 min after release from araC. (b) Western blots for pRB with sc-102 and Rb-C (cf. legend to Figure 2) . At 105 and 120 min after release from araC, the amount of intact pRB detected by Rb-C was approximately 25% of the maximum Figure 2 Apoptosis is associated with pRB dephosphorylation and cleavage. HL-60 cells were prepared as in Figure 1 , except that they were also labeled with 32 P-inorganic phosphate. The illustrations represent data from one typical experiment. The molecular changes in pRB were then analysed by immunoprecipitation followed by (a) autoradiography or (b) Western blots with antibodies recognizing both intact and truncated pRB (sc-102, top panels) or intact pRB only (Rb-C, bottom panels). As expected during this phase of the cell cycle, cells not exposed to araC were found to contain heavily phosphorylated pRB (a, top panels). The phosphate content of pRB decreased to about one ®fth of the maximum within 3 h after release from araC, whereas the ratio slow pRB:fast pRB decreased from *12 to *0.1, and the amount of pRB protein detected by Rb-C decreased by about 63%. The vertical arrows indicate a noticeable change in the migration pattern of pRB. See text for a further discussion pho-pRB was incubated with caspase-3, or with PP1a ®rst, and then with caspase-3.
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P-incorporation into pRB shows that the three Cdk/cyclin complexes phosphorylated pRB either individually or jointly under these reaction conditions (Figure 4 , top panels). Phosphorylation of pRB by all three Cdk/cyclin complexes (the situation which most closely resembles the in vivo conditions during S phase) was able to completely block caspase-3 digestion (Figure 4 , bottom panels, 4th blot). Remarkably, Cdk2/cyclin E alone was as ecient in preventing pRB proteolysis ( Figure  4 , bottom panels, 2nd blot). The other two kinases, Cdk4/cyclin D1 and Cdk2/cyclin A, were able to delay caspase-3 action individually. However, prior dephos- Figure 4 pRB needs to be dephosphorylated in order to be a substrate for caspase-3. Human pRB, obtained from overexpression in Sf9 cells, was phosphorylated in vitro with the same three Cdk/cyclin complexes that are believed to phosphorylate pRB in vivo, and then incubated with caspase-3, either before or after dephosphorylation with PP1a. The ®gure shows the autoradiograph of immunoprecipitated pRB electrotransferred to Immobilon-P (top panels), and Western blots for pRB with sc-102 (center panels), and Rb-C (bottom panels) (cf. legend to Figure 2 ). The various additions to each reaction are indicated at the top of the ®gure Figure 5 pRB isolated from cells committed to S phase entry is not a substrate for caspase-3. In this experiment we compared the susceptibility of recombinant pRB to caspase-mediated digestion to that of pRB immunoprecipitated from human HL-60 cells that had been synchronized at G1/S. It is believed that at this time most of the pRB sites are already phosphorylated. The left panel is identical to Figure 4 , except that unphosphorylated pRB was also included: The results demonstrate that pRB was eectively proteolyzed before phosphorylation (lane 2) or after dephosphorylation (lane 6), but not after phosphorylation (lane 4).`Native' pRB from G1/S synchronized cells showed a proteolytic digestion pattern that was identical to that of recombinant pRB (central panel), while the addition of Cdk/cyclin complexes did not change pRB's reactivity with caspase-3 (right panel). The various additions to each reaction are indicated at the top of the ®gure phorylation of phospho-pRB by PP1a resulted in ecient caspase-3 digestion of pRB (Figure 4 , bottom panels, last lane of each blot). Thus it appears that dephosphorylation of pRB is required to convert phospho-pRB into an ecient caspase substrate.
Next, we compared caspase-3 digestion of in vitro phosphorylated pRB with that of pRB immunoprecipitated from G1/S arrested HL-60 cells, at which time pRB would be almost maximally phosphorylated. The results are shown in Figure 5 and con®rmed our conclusion that pRB is only an ecient substrate for caspase-3 before phosphorylation (presumably in G0 through mid G1) and after dephosphorylation. pRB that was isolated from cells synchronized at G1/S behaved in a fashion identical to the recombinant pRB phosphorylated by three Cdk/cyclin complexes ( Figure  5 , left and center).
PP1a activity is sufficient to induce signs of apoptosis
We have shown earlier that introduction of moderate amounts of PP1a can cause both pRB +/+ and pRB
cells to die (Berndt et al., 1997) . Since the focus of that study was to identify roles of PP1 in the cell cycle, this ®nding was not stringently evaluated. Therefore, we now asked the question whether PP1a can induce apoptosis. When HL-60 cells were electroporated in the presence of PP1, wild-type PP1a was unable to induce DNA fragmentation; likewise, heat-inactivated PP1a T320A had no eect. However, cells treated with the constitutively active form, PP1aT320A, showed signs of DNA laddering within 2 h after the electroporation ( Figure 6 ). The apoptotic index of these cells increased to almost 20% within 3 h. This suggests that PP1a activity is crucial and perhaps sucient to launch apoptosis. Next, we examined the status of PP1 and pRB in wild-type CEM/0 and araC-resistant CEM/I cells. The latter do not undergo apoptosis in response to high concentrations of araC (Martin-Aragon et al., 2000) .
We reasoned that the observed behavior of PP1 in these cells would enable us con®rm and/or narrow down the role(s) of PP1 in apoptosis. Like HL-60 cells, CEM/0 cells showed a similar, i.e. approximately twofold, increase in PP1a protein (Figure 7a , left panel). This was associated with a small increase in PP1 activity (Figure 7b) , an increased mobility of pRB, apparent cleavage of pRB (Figure 7c, left panel) as well as signs of apoptosis in response to araC treatment (Figure 7d, left panel) . Whereas a twofold induction of PP1a occurred within 1 h of exposure to araC, we note that PP1d expression also increased about threefold, but not until 5 h after release from araC. Interestingly, treatment of araC-resistant CEM/I cells with araC did not yield any changes in any PP1 isozyme, PP1 activity, pRB or DNA fragmentation (Figure 7 , right panels). On the other hand, electroporation of CEM/I cells with PP1aT320A resulted in changes identical to those produced by araC: The apoptotic index was signi®cantly increased (Figure 8a ), pRB moved faster in SDS gels, and full-length pRB disappeared ( Figure  8b ). The eciency of the electroporation is shown in Figure 8c : The amount of PP1aT320A increased approximately threefold. This suggests that CEM/I cells did not lose their ability to die in general, and that PP1a may be a target for araC and other apoptotic agents. We con®rmed this hypothesis by the observation that both actinomycin D and etoposide resulted in induction of PP1a and cell death (data not shown).
Inhibitor-2 negatively regulates apoptosis
Regardless of whether PP1a is necessary or sucient to initiate or execute apoptosis, one would expect that PP1 antagonists play a negative role in apoptosis. To test this idea, the HL-60 cells shown in Figure 6 were also subjected to electroporation with inhibitor-2, the question being whether this PP1-speci®c inhibitor counteracts araC-or PP1a-induced apoptosis. As shown in Figure 9a , inhibitor-2 was able to delay the onset of apoptosis mediated by ara-C. On the other hand, inhibitor-2 eectively blocked apoptosis induced by PP1aT320A (Figure 9c ). Western blots for inhibitor-2 or the two PP1a species revealed that the electroporation resulted in a signi®cant uptake of the foreign proteins (Figure 9b,d) .
Discussion
During the last few years, two concepts have emerged that would suggest a negative role for protein phosphatases in the regulation of the cell number. First, protein phosphorylation is a major driving force in cell cycle progression. Second, protein phosphorylation appears to support cell survival and to counteract apoptosis, e.g. by phosphorylating pro-apoptotic BAD or directly inhibiting apoptotic proteases of the caspase family. Both of these pathways involve protein kinase B (Cardone et al., 1998; Downward, 1998) . Besides, a positive role for protein phosphatases in apoptosis is Figure 6 Elevated PP1a activity triggers DNA fragmentation. Non-synchronized HL-60 cells were electroporated in the presence of wild-type PP1a, heat-inactivated PP1aT320A (h.i.PP1aCA), or constitutively active PP1aT320A (PP1aCA) as described (Berndt et al., 1997) . The degree of DNA fragmentation was then assessed over a period of 3 h as described in Materials and methods. The ®rst lane shows DNA size markers Roles of PP1 in apoptosis R-H Wang et al supported by the following observations: Thus, PP2B-mutants insensitive to calcium induce apoptosis in neurons, and this may be due to PP2B-mediated dephosphorylation of BAD (Shibasaki and McKeon, 1995; Wang et al., 1999) . Furthermore, short-term inhibition of phosphatases with okadaic acid, calyculin A, and cantharidin prevents DNA fragmentation, PARP cleavage and pRB mobility shift by several apoptosis-inducing agents (Morana et al., 1996) . The analysis and an understanding of apoptosis is dicult, since it is more likely that it requires the co-operation of many proteins and pathways, rather than the activation of a single one (Green, 1998; Martin and Green, 1995) . A second major challenge is to understand the co-ordinated control of apoptosis with cell cycle progression or cellular homeostasis: We have shown previously that one of the major mammalian protein phosphatases, PP1a, can induce pRB-depen- dent cell cycle arrest (Berndt et al., 1997) . The interest in pRB function, its regulators and downstream targets is of course justi®ed by its assumed role as a tumor suppressor. As apoptosis ultimately results in termination of the cell cycle, it is not surprising that in the last few years, several proteins that control cell cycle progression have also been implicated in apoptosis. One of them is pRB.
As was alluded to in the Introduction, early studies on the roles of pRB in apoptosis created a paradox:
How can pRB be a tumor suppressor and at the same time inhibit apoptosis? This question was a sucient reason for us to undertake the current study in which we focused on the interaction between pRB and PP1 during experimentally induced apoptosis. That PP1 directly and indirectly controls the cell cycle-dependent phosphorylation state of pRB has been established by several groups (Alberts et al., 1993; Berndt, 1995; Durfee et al., 1993; Ludlow et al., 1993) .
Using the anticancer drug araC as an apoptotic signal for HL-60 leukemia cells, we show here that PP1 is activated before cells execute cell death. This seemed to be largely due to a rather rapid increase in the expression level of PP1a. The transient activation of PP1a was accompanied by dephosphorylation of pRB, which was followed by (probably caspase-mediated) cleavage of pRB (see Figure 3) . All of these events occurred within 2 h after releasing the cells from araC exposure, whereas the appearance of cells with 52n DNA content did not occur until 5 h (cf. Figure 1e ). It should also be noted that the activation of PP1 occurred during S phase, when PP1 activity is at its cell cycle-dependent minimum (Dohadwala et al., 1994) . Proteolytic digestion of pRB that was phosphorylated by Cdks in vitro, was either delayed or completely inhibited, whereas PP1a-mediated dephosphorylation enabled caspase-3 to cleave pRB (see Figure 4) . Likewise, caspase-3 could easily cleave unphosphorylated pRB, the form that prevails during G0 and most of G1 phases (see Figure 5) .
It is tempting to speculate that araC induces an abrupt halt of DNA replication (S phase), that this alone might be sucient to induce apoptosis, and that the phenomena we observed here are secondary eects. However, such an explanation appears unlikely as PP1a activity was found to induce cell death (Berndt et al., 1997) or apoptosis (this study, see Figure 6 ). Furthermore, the transient induction and activation of PP1a (see Figure 1) did not depend on expression of pRB. AraC treatment led to a more marked increase in PP1a protein in pRB 7/7 Saos-2 cells (data not shown). The failure of araC-resistant CEM/I cells to induce PP1a in response to araC treatment would indicate that PP1a activity is necessary for apoptosis (see Figure  7a ,b). However, another interpretation is more likely: The fact that inhibitor-2 completely abolished PP1a-mediated apoptosis, yet only delayed the onset of araC-induced apoptosis (see Figure 9 ), supports the idea that PP1a may simply be one (of many?) protein(s) that is capable of launching apoptosis. Thus, one or several functions carried out by PP1a may be sucient to trigger apoptosis. Since inhibition of PP1a, and presumably other PP1 isoforms, does not prevent araC-induced apoptosis (see Figure 9a ), araC and perhaps other pro-apoptotic signals cannot rely on PP1 alone, in other words, PP1 is not absolutely required for apoptosis. Nonetheless, the induction of apoptosis in CEM/I cells following electroporation with PP1a T320A underlines the critical role of PP1 activity. Together, our ®ndings as well as those of other laboratories support the notion that there are several distinct and independent roads to cell death. Our ®ndings appear to be able to resolve the aforementioned paradox with regards to pRB function: the antiapoptotic function of pRB is most certainly restricted to the phosphorylated form of the molecule, which prevails during S phase, a time when cells are replicating DNA. This interpretation would also be consistent with a recent study reporting that constitutively active (phosphorylation-resistant) pRB causes both cell cycle arrest and apoptosis (Knudsen et al., 1999) .
The data presented here, together with earlier results from our laboratory, support the hypothesis that the PP1-pRB interaction is an important, yet non-essential step for cells launching apoptosis. While it may be necessary to dephosphorylate pRB in cells that express it, we cannot rule out that this function may be assumed by a phosphatase other than PP1a. Our ®ndings that PP1d increased in response to araC, albeit much later than PP1a, are in agreement with a report describing a crucial interaction between PP1d and pRB, although those experiments involved mitotic HeLa cells (Puntoni and Villa-Moruzzi, 1999) . At any rate, we have already reported that Saos-2 cells, which lack functional pRB, also die following electroporation in the presence of PP1a (Berndt et al., 1997) . This suggests that PP1a is able to utilize more than one pathway to trigger or facilitate apoptosis. That this is the case is consistent with a recent study showing that PP1a dephosphorylates and activates BAD (AylloÂ n et al., 2000). We have also observed that in HL-60 and HeLa cells, PP1a was associated with procaspase-9 and phosphorylated BAD (Rui-Hong Wang and Norbert Berndt, unpublished) .
In summary, our data indicate that hypo-or unphosphorylated pRB is at least compatible with, if not required for, apoptosis. Also, inhibition of apoptosis by phospho-pRB can more easily be reconciled with its role as a tumor suppressor and with a recent report describing that phospho-pRB stimulates DNA polymerase (Takemura et al., 1997) . Most importantly, we have presented evidence that a protein phosphatase acts to recruit an apparent death substrate such as pRB to a caspase, thereby permitting its proteolytic destruction. Our ®ndings suggest that PP1a functions to activate apoptosis and may be sucient to trigger apoptosis, and may be able to overcome drug resistance under speci®c circumstances. Furthermore, since the inability to be phosphorylated (inhibited) by Cdks enabled PP1a to induce apoptosis, these ®ndings suggest yet another link between regulation of the cell cycle and programmed cell death. A future challenge will be to understand to what extent PP1's functions in both cell cycle control and apoptosis are integrated or regulated dierentially. 
Materials and methods
Cells, vectors and proteins
Human promyelocytic leukemia HL-60 cells were obtained from the ATCC, araC-resistant leukemia CEM/I cells were obtained from parental CEM/0 cells as described (MartinAragon et al., 2000) .
Recombinant PP1a was obtained via overexpression in E.coli as described (Dohadwala and Berndt, 1998) . Phosphorylase b and phosphorylase kinase, both necessary to prepare PP1 substrate, was a gift from Balwant S Khatra (California State University, Long Beach, CA, USA). Recombinant baculoviruses encoding human pRB was a gift from Barbara Driscoll (Childrens Hospital, Los Angeles, CA, USA), and baculoviruses encoding mammalian Cdk 2, Cdk4, cyclin D1, cyclin E, and cyclin A were kindly provided by Charles J Sherr (St. Jude's Childrens Research Hospital, Memphis, TN, USA) and David O Morgan (University of California, San Francisco, CA, USA), respectively.
Antibodies to the three ubiquitously expressed isozymes of PP1 were obtained from Emma Villa-Moruzzi (University of Pisa, Italy). Two pRB antibodies were used: sc-102 (speci®c for the centrally located A/B pocket region, Santa Cruz Biotechnology) and Rb-C (speci®c for the C-terminus of pRB, New England Biolabs). Inhibitor-2 was purchased from Upstate Biotechnology, Inc., the antibody to inhibitor-2 was from BD Transduction Laboratories, and caspase-3 from Bio-Mol. All other materials were from Sigma, unless otherwise stated.
Cell culture and metabolic labeling
HL-60 cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum and antibiotics (100 units/ml of penicillin G and 100 mg/ml streptomycin). After synchronizing the cells at the G1/S boundary with 5 mg/ ml aphidicolin for 16 h, the cells were washed twice to remove the drug, and araC (Bedford Laboratories, dissolved in phosphate-buered saline) was added to reach a ®nal concentration of 10 mM for 2 h. For pRB phosphorylation analyses, 1610 6 cells were metabolically labeled for 2 h with 200 mCi 32 P-orthophosphate (ICN) in 1 ml (Berndt et al., 1997; Liu et al., 1999) in the presence of 10 mM araC. The cells were washed several times to remove araC (and 32 P) and incubated further. The cells were collected, washed twice with PBS and split into several aliquots for further analyses.
In vitro pRB phosphorylation, dephosphorylation and caspase-3 digestion pRB, Cdk2/cyclin A, Cdk2/cyclin E, Cdk4/cyclin D1 were expressed in Sf9 cells by recombinant baculovirus infection. Sf9 cells ( 10 7 ) were co-infected with baculoviruses encoding cyclin A or cyclin E and Cdk2, cyclin D1 and Cdk4 and lysed in kinase reaction buer (20 mM Tris-HCl, pH 7.5, 20 mM MgCl 2 , 10 mM b-mercaptoethanol supplemented with 150 mM NaCl and 0.5% NP-40 plus the following protease and phosphatase inhibitors: 2 mg/ml aprotonin, 1 mM benzamidine, 0.5 mg/ml leupeptin, 1 mg/ml pepstatin A, 0.1 mM PMSF, 25 mM NaF, 1 mM sodium b-glycerophosphate, 1 mM Na 3 VO 4 ). Clari®ed lysates were used to phosphorylate pRB immunoprecipitated from pRB-overexpressing Sf9 cells in the presence of [g-32 P]ATP (Mihara et al., 1989) . After phosphorylation, the protein G beads were washed 6 ± 10 times with EBC buer (50 mM tris-HCl, pH 8.0, 150 mM NaCl, 0.5% NP-40) to remove the protein kinases and ATP and incubated with 20 units of PP1a at 308C for 20 min. PP1a-treated pRB (on beads) was washed 6 ± 10 times with EBC buer, resuspended in 150 ml of digestion buer (50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol, 10 mM DTT) plus 50 ml of 2 units/ml caspase-3 and incubated at 378C overnight. The samples were concentrated by Microcon YM-10 centrifugal ®lter devices (Millipore), separated by SDS ± PAGE and analysed by autoradiography and pRB Western blot.
Electrotransfer of purified proteins into HL-60 or CEM/I cells To introduce foreign proteins into cells, we modi®ed the procedure described in detail (Berndt et al., 1997) . Approximately 2610 6 cells in 200 ml were subjected to a pulse of 200 V at a capacitance setting of 250 mF in the presence of 200 units of PP1a or PP1aT320A, or 10 mg of inhibitor-2.
Apoptosis assays
To determine cell viability, cells were stained with trypan blue immediately after collection. To determine DNA fragmentation, approximately 10 6 cells were lysed with a solution consisting of 10 mM tris-HCl, pH 8.0, 10 mM EDTA, and 1% Triton X-100. The post-nuclear lysates were obtained by spinning the cell lysates at 48C at 14 000 r.p.m. for 30 min. Phenol-chloroform extraction was performed and ethanol precipitation was carried out at 7208C overnight. The precipitated DNA was loaded onto a 2% agarose gel after RNase A treatment (Yi et al., 1997) . To determine the apoptotic index, cells were stained with Hoechst 33258 (Spector et al., 1998) ; cells showing irregular nuclear staining (due to chromatin condensation and nuclear fragmentation) were scored as apoptotic (Spector et al., 1998) , and divided by the number of all Hoechst 33258-positive cells.
Flow cytometry analysis
2610
6 cells per sample were washed twice with PBS, ®xed in 70% icecold ethanol and incubated overnight at 7208C. The cells were spun down, washed twice with PBS, and extracted with a buer (45 mM Na 2 HPO 4 , 2.5 mM citric acid, 0.1% Triton X-100) at room temperature for 30 min. The extraction buer was washed away with PBS and the cells were digested with 10 mg/ml RNase A (DNase free) at 378C for 20 min (Hotz et al., 1994) . Propidium iodide was added to each sample at a ®nal concentration of 20 mg/ml. The samples were kept on ice for 1 h before being analysed in ā ow cytometer (FACS 440, . To estimate the portion of cells in G1 and G2, the resulting histograms were analysed with ModFit LT 2.0 software. Cells with a DNA content less than 2n were considered to be undergoing (or committed to) apoptosis (Spector et al., 1998) .
Immunoprecipitation, electrophoresis, and Western blotting
Washed cells were lysed in EBC buer, and the protein concentration was determined with the Bio-Rad protein assay (Bradford, 1976) . 1.2 mg of total protein from each sample was pre-cleared with 1 mg of normal mouse IgG plus 20 ml of protein G-sepharose (Santa Cruz Biotechnology) in 1 ml of EBC buer at 48C for 4 h. The suspensions were centrifuged and the supernatants were mixed with 2 mg of sc-102 and rotated overnight at 48C. Twenty ml of protein G-sepharose beads were added to the mixture 4 h before the beads were centrifuged, recovered and washed with EBC buer at least six times at 48C. Finally, 20 ± 40 ml of 26 SDS ± PAGE loading buer was used to resuspend each precipitate. The samples were boiled for 10 min and centrifuged brie¯y to remove insoluble material.
Cells were lysed with EBC buer (for pRB Western blot) or lysis buer A (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.1 mM EDTA, 0.1 mM EGTA, for PP1 Western blot), and the lysates or immunoprecipitated proteins were separated by SDS ± PAGE (Novex, 12% Tris-glycine gel for PP1, 6% Tris-glycine gel for pRB) (Laemmli, 1970) . Care was taken to load an equal number of cells or an equal protein amount per lane. After electrophoresis, the samples were electrotransferred to Immobilon-P (Millipore) at a constant voltage of 30 V. Membranes containing 32 P-labeled pRB were exposed to Kodak X-Omat AR ®lm. For immunoblotting, the membranes were blocked overnight at room temperature with 5% non-fat milk in TBS (25 mM Tris-HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl) and incubated with the primary antibodies to PP1 isozymes or pRB. They were diluted with 2% BSA in TBST (TBS containing 0.2% tween-20) and added to the membranes for 2 h at room temperature. After washing with TBST for 3615 min, secondary antibodies diluted with 2% BSA in TBST were added for 1 h at room temperature. After washing 3615 min with TBST, the proteins were visualized with the ECL reagents according to the manufacturer's instructions (Amersham). The slow and fast migrating forms of pRB are indicated by arrows on the righthand side of the ®gures.
Autoradiographs and Western blots were scanned with a GS300 densitometer (Hoefer Scienti®c Instruments) to estimate the relative amount of proteins. The intensity of the bands was determined with GS370 v.3 software. All statements referring to quantitative changes in band intensities in the text or ®gure legends are based on these analyses.
PP1 activity assay
PP1 activity was measured by using 32 p-phosphorylase a as a substrate as described previously (Dohadwala et al., 1994) .
